The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Systemic Inflammation Predicts All-Cause Mortality: A Glasgow Inflammation Outcome Study
Open accessAbstract
INTRODUCTION: Markers of the systemic inflammatory response, including C-reactive protein and albumin (combined to form the modified Glasgow Prognostic Score), as well as neutrophil, lymphocyte and platelet counts have been shown to be prognostic of survival in patients with cancer. The aim of the present study was to examine the prognostic relationship between these markers of the systemic inflammatory response and all-cause, cancer, cardiovascular and cerebrovascular mortality in a large incidentally sampled cohort. METHODS: Patients (n = 160 481) who had an incidental blood sample taken between 2000 and 2008 were studied for the prognostic value of C-reactive protein (>10mg/l, albumin (>35mg/l), neutrophil (>7.5×109/l) lymphocyte and platelet counts. Also, patients (n = 52 091) sampled following the introduction of high sensitivity C-reactive protein (>3mg/l) measurements were studied. A combination of these markers, to make cumulative inflammation-based scores, were investigated. RESULTS: In all patients (n = 160 481) C-reactive protein (>10mg/l) (HR 2.71, p<0.001), albumin (>35mg/l) (HR 3.68, p<0.001) and neutrophil counts (HR 2.18, p<0.001) were independently predictive of all-cause mortality. These associations were also observed in cancer, cardiovascular and cerebrovascular mortality before and after the introduction of high sensitivity C-reactive protein measurements (>3mg/l) (n = 52 091). A combination of high sensitivity C-reactive protein (>3mg/l), albumin and neutrophil count predicted all-cause (HR 7.37, p<0.001, AUC 0.723), cancer (HR 9.32, p<0.001, AUC 0.731), cardiovascular (HR 4.03, p<0.001, AUC 0.650) and cerebrovascular (HR 3.10, p<0.001, AUC 0.623) mortality. CONCLUSION: The results of the present study showed that an inflammation-based prognostic score, combining high sensitivity C-reactive protein, albumin and neutrophil count is prognostic of all-cause mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a recent study of more than 160,000 people from North Glasgow found that a combination of the inflammatory markers CRP (>10 mg/L; HR 2.71, P < 0.001), albumin (>35 mg/L; HR 3.68, P < 0.001) and neutrophil count (HR 2.18, P < 0.001) predicted all-cause mortality over 8 years, in addition to mortality due to cancer, cardiovascular and cerebrovascular disease45.”
From Chronic inflammation in the etiology of disease across the life span (2019) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,873
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Guthrie, G. J. K., Charles, K. A., Roxburgh, C. S. D., Horgan, P. G., McMillan, D. C., & Clarke, S. J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.010 · Cited by 1,552 · cited 2×
“Similarly, neutrophils and lymphocytes using standard thresholds (termed the neutrophil lymphocyte ratio, NLR) have also been shown to have independent prognostic value [2].”
BackgroundSelf-citationMcMillan, D. C. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.08.003 · Cited by 1,398 · cited 2×
“With reference to cancer, the role of markers of the systemic inflammatory response in predicting outcome has become recognised [1,2] and the clinical utility of combining such markers with tumour based factors to provide improved patient counselling and personalised treatment is becoming increasingly recognised [25–2…”
BackgroundSelf-citation2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,324
C-reactive protein, fibrinogen, and cardiovascular disease prediction
The Emerging Risk Factors Collaboration (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107477 · Cited by 1,150
Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles
Bastani, R., Glenn, B. A., & Maxwell, A. E. (2015) · eCite Digital Repository (University of Tasmania) · doi:10.1158/1055-9965 · Cited by 901
Proctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., Fletcher, C. D., O’Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.028 · Cited by 757 · cited 1×
“From previously published work on the present cohort, cumulative scores based onmarkers of the systemic inflammatory response, were reported to predict cancer outcomes [21].”
BackgroundSelf-citationAssociation of serum albumin and mortality risk
Goldwasser, P., & Feldman, J. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00015-2 · Cited by 716 · cited 1×
“There have also been occasional reports of other markers of the systemic inflammatory response, including albumin [10,11], neutrophil count [12], lymphocyte count [13,14] and platelet count [15] being associated with allcause mortality.”
BackgroundC-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000093381.57779.67 · Cited by 448
C-Reactive Protein in Ischemic Stroke: An Independent Prognostic Factor
Di Napoli, M., Papa, F., & Bocola, V. (2001) · Stroke · doi:10.1161/01.str.32.4.917 · Cited by 389
Cancer and systemic inflammation: treat the tumour and treat the host
Roxburgh, C. S. D., & McMillan, D. C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.90 · Cited by 368 · cited 1×
“association between the systemic inflammatory response and cancer mortality, when compared with cardiovascular and cerebrovascular mortality, is not clear but highlights the potential of the systemic inflammatory response as a therapeutic oncological target [23,24].”
BackgroundSelf-citationPietlla, K. O., Harmoinen, A. P., Jokiniitty, J., & Pasternack, A. I. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015068 · Cited by 263 · cited 1×
“It is therefore of interest that there have been numerous reports investigating the relationship between an elevated C-reactive protein concentration and increased risk of cardiovascular [4–6], cerebrovascular [5,7] and all-cause mortality [8,9].”
BackgroundProctor, M. J., Talwar, D., Balmar, S. M., O'Reilly, D. S. J., Foulis, A. K., Horgan, P. G., Morrison, D. S., & McMillan, D. C. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605855 · Cited by 204
Self-citationAcanfora, D., Gheorghiade, M., Trojano, L., Furgi, G., Pasini, E., Picone, C., Papa, A., Iannuzzi, G. L., Bonow, R. O., & Rengo, F. (2001) · American Heart Journal · doi:10.1067/mhj.2001.115792 · Cited by 186 · cited 1×
“There have also been occasional reports of other markers of the systemic inflammatory response, including albumin [10,11], neutrophil count [12], lymphocyte count [13,14] and platelet count [15] being associated with allcause mortality.”
Backgroundthe PAIS investigators, Hertog, H. M., Rossum, J. A., Worp, H. B., Gemert, H. M. A., Jonge, R., Koudstaal, P. J., & Dippel, D. W. J. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5228-x · Cited by 163 · cited 1×
“It is therefore of interest that there have been numerous reports investigating the relationship between an elevated C-reactive protein concentration and increased risk of cardiovascular [4–6], cerebrovascular [5,7] and all-cause mortality [8,9].”
BackgroundGillum, R. F., Mussolino, M. E., & Madans, J. H. (2004) · Annals of Epidemiology · doi:10.1016/j.annepidem.2004.08.009 · Cited by 130 · cited 1×
“There have also been occasional reports of other markers of the systemic inflammatory response, including albumin [10,11], neutrophil count [12], lymphocyte count [13,14] and platelet count [15] being associated with allcause mortality.”
BackgroundC-reactive protein and all-cause mortality--the Copenhagen City Heart Study
Zacho, J., Tybjærg–Hansen, A., & Nordestgaard, B. G. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq103 · Cited by 122 · cited 1×
“It is therefore of interest that there have been numerous reports investigating the relationship between an elevated C-reactive protein concentration and increased risk of cardiovascular [4–6], cerebrovascular [5,7] and all-cause mortality [8,9].”
BackgroundHigh-Sensitivity C-Reactive Protein and Cancer
Lee, S., Choe, J. W., Kim, H., & Sung, J. (2011) · Journal of Epidemiology · doi:10.2188/jea.je20100128 · Cited by 120 · cited 1×
“High sensitivity Creactive protein threshold>3mg/l, previously reported to be associated with survival [17–20] and shown to be the optimal threshold in this cohort [3], was also studied.”
BackgroundOptimization of the systemic inflammation‐based Glasgow Prognostic Score
Proctor, M. J., Horgan, P. G., Talwar, D. K., Fletcher, C. D., Morrison, D. S., & McMillan, D. C. (2013) · Cancer · doi:10.1002/cncr.28018 · Cited by 116
Self-citationC-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort
Marsik, C. L., Kazemi-Shirazi, L., Schickbauer, T., Winkler, S., Joukhadar, C., Wagner, O. F., & Endler, G. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.091959 · Cited by 112 · cited 3×
“The sample size was originally based on similar work investigating the association between C-reactive protein and all-cause survival [8].”
BackgroundResultGakis, G., Todenhöfer, T., Renninger, M., Schilling, D., Sievert, K., Schwentner, C., & Stenzl, A. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10234.x · Cited by 94
Chronic stress, allostatic load, and aging in nonhuman primates
Maestripieri, D., & Hoffman, C. L. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000551 · Cited by 91 · cited 1×
“This ‘wear and tear’ occurs as a consequence of the repeated activation of compensatory physiological mechanisms to chronic stress, including the hyperactivation of the hypothalamic-pituitary axis [31].”
BackgroundZamani, P. L., Schwartz, G. G., OLSSON, A. G., Rifai, N., Bao, W., Libby, P., Ganz, P., Kinlay, S., & for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.003103 · Cited by 91 · cited 1×
“It is therefore of interest that there have been numerous reports investigating the relationship between an elevated C-reactive protein concentration and increased risk of cardiovascular [4–6], cerebrovascular [5,7] and all-cause mortality [8,9].”
BackgroundHigh-Sensitivity C-Reactive Protein Levels and Cancer Mortality
Ko, Y.-J., Kwon, Y.-M., Kim, K. H., Choi, H.-C., Chun, S., Yoon, H., Goh, E., Cho, B., & Park, M. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0611 · Cited by 90 · cited 1×
“High sensitivity Creactive protein threshold>3mg/l, previously reported to be associated with survival [17–20] and shown to be the optimal threshold in this cohort [3], was also studied.”
BackgroundInoue, Y., Iwata, T., Okugawa, Y., Kawamoto, A., Hiro, J., Toiyama, Y., Tanaka, K., Uchida, K., Mohri, Y., Miki, C., et al. (2012) · Oncology · doi:10.1159/000343822 · Cited by 77 · cited 1×
“With reference to cancer, the role of markers of the systemic inflammatory response in predicting outcome has become recognised [1,2] and the clinical utility of combining such markers with tumour based factors to provide improved patient counselling and personalised treatment is becoming increasingly recognised [25–2…”
BackgroundLamb, G. W. A., Aitchison, M., Ramsey, S., Housley, S. L., & McMillan, D. C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.556 · Cited by 69
Self-citationGay, J. L., Salinas, J. J., Büchner, D. M., Mirza, S., Kohl, H. W., Fisher‐Hoch, S. P., & McCormick, J. B. (2013) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-013-9950-1 · Cited by 62
Sex differences in the association between albumin and all‐cause and vascular mortality
Grimm, G., Haslacher, H., Kampitsch, T., Endler, G., Marsik, C. L., Schickbauer, T., Wagner, O. F., & Jilma, B. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02189.x · Cited by 52 · cited 2×
“There have also been occasional reports of other markers of the systemic inflammatory response, including albumin [10,11], neutrophil count [12], lymphocyte count [13,14] and platelet count [15] being associated with allcause mortality.”
BackgroundResultRidker, P. M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.099465 · Cited by 51
Cancer and systemic inflammation: stage the tumour and stage the host
McMillan, D. C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.418 · Cited by 45 · cited 1×
“association between the systemic inflammatory response and cancer mortality, when compared with cardiovascular and cerebrovascular mortality, is not clear but highlights the potential of the systemic inflammatory response as a therapeutic oncological target [23,24].”
BackgroundSelf-citationPhillips, A. C., Carroll, D., Galé, C. R., Drayson, M. T., & Batty, G. D. (2010) · QJM · doi:10.1093/qjmed/hcq199 · Cited by 16
Sokunbi, D., Wadhwa, N. K., & Suh, H. (1994) · PubMed · Cited by 15
Hemelrijck, M. V., Eichholzer, M., Faeh, D., & Rohrmann, S. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-895 · Cited by 14
Cited by
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Sarcopenia: A Contemporary Health Problem among Older Adult Populations
Papadopoulou, S. (2020) · Nutrients · doi:10.3390/nu12051293 · Cited by 588
Furman, D., Chang, J., Lartigue, L., Bolen, C. R., Haddad, F., Gaudilliere, B., Ganio, E. A., Fragiadakis, G. K., Spitzer, M. H., Douchet, I., et al. (2017) · Nature Medicine · doi:10.1038/nm.4267 · Cited by 389
A wireless patch for the monitoring of C-reactive protein in sweat
Tu, J., Min, J., Song, Y., Xu, C., Li, J., Moore, J., Hanson, J., Hu, E., Parimon, T., Wang, T.-Y., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01059-5 · Cited by 395
“10 and 11).”
Dolan, R. D., McSorley, S. T., Horgan, P. G., Laird, B., & McMillan, D. C. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.06.002 · Cited by 351
Self-citation
Metadata
- Authors
- Proctor, M. J., McMillan, D. C., Horgan, P. G., Fletcher, C. D., Talwar, D., & Morrison, D. S.
- Affiliations
- University of Glasgow (GB)
- Glasgow Royal Infirmary (GB)
- Corresponding author
- Proctor, Michael J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-02
- Volume
- 10
- Issue
- 3
- Pages
- e0116206
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4346265
- OpenAlex
- W2040620505
- Cited by
- 168
- References
- 33
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 21 · 2023: 15 · 2022: 21 · 2021: 20 · 2020: 18 · 2019: 11 · 2018: 12 · 2017: 11 · 2016: 8 · 2015: 3
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- systemic inflammation, C-reactive protein, high-sensitivity C-reactive protein, albumin, neutrophil count, lymphocyte count, platelet count, modified Glasgow Prognostic Score, all-cause mortality, cancer mortality, cardiovascular mortality, cerebrovascular disease mortality, prognostic factors, mortality prediction
- MeSH terms
- Aged, Aged, 80 and over, Blood Platelets, C-Reactive Protein, Cardiovascular Diseases, Cerebrovascular Disorders, Female, Follow-Up Studies, Humans, Inflammation, Leukocyte Count, Lymphocytes, Male, Middle Aged, Neoplasms, Neutrophils, Platelet Count, Prognosis, Serum Albumin, Cohort Studies, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.